{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:10:08Z","timestamp":1793387408434,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-075-068"],"award-info":[{"award-number":["110-2314-B-075-068"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-010-050-MY3"],"award-info":[{"award-number":["109-2314-B-010-050-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V111C-044"],"award-info":[{"award-number":["V111C-044"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-140"],"award-info":[{"award-number":["V112C-140"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-111"],"award-info":[{"award-number":["V112C-111"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V111C-029"],"award-info":[{"award-number":["V111C-029"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaad.2024.12.025","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T07:15:17Z","timestamp":1735370117000},"page":"1015-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12\/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis"],"prefix":"10.1016","volume":"92","author":[{"given":"Tai-Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2024.12.025_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2024.12.025_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/ds.DS-D-24-00061","article-title":"Phenotypic differences in clinical manifestations of generalized pustular psoriasis and severe plaque psoriasis in tropical Taiwan","volume":"42","author":"Chao","year":"2024","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaad.2024.12.025_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/ds.DS-D-24-00070","article-title":"Taiwanese Dermatological Association consensus recommendations for the diagnosis, treatment, and management of generalized pustular psoriasis","volume":"42","author":"Hsu","year":"2024","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaad.2024.12.025_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaad.2024.12.025_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamadermatol.2021.4918","article-title":"Association of psoriasis with incident venous thromboembolism and peripheral vascular disease: a systematic review and meta-analysis","volume":"158","author":"Chen","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070750","article-title":"Immunity: psoriasis comorbid with atherosclerosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2024.12.025_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688861","article-title":"Thrombosis in psoriasis: cutaneous cytokine production as a potential driving force of haemostatic dysregulation and subsequent cardiovascular risk","volume":"12","author":"Visser","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2024.12.025_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard-2024-225534","article-title":"Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis","volume":"83","author":"Kerschbaumer","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2024.12.025_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/rheumatology\/keab522","article-title":"Risk of major adverse cardiovascular events in patients initiating biologics\/apremilast for psoriatic arthritis: a nationwide cohort study","volume":"61","author":"Pina Vegas","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2024.12.025_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152416","article-title":"Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: a population-based cohort study","volume":"65","author":"Meng","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2024.12.025_bib11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cgh.2023.09.033","article-title":"Risk of major adverse cardiovascular events in immune-mediated inflammatory disorders on biologics and small molecules: network meta-analysis","volume":"22","author":"Mattay","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/ds.DS-D-20-00042","article-title":"Risk of thyroid diseases in patients with psoriasis: a systematic review and meta-analysis of cohort studies","volume":"42","author":"Jiesisibieke","year":"2024","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaad.2024.12.025_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaad.2024.12.025_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2024.12.025_bib16","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2024.12.025_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2024.12.025_bib18","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2665-9913(23)00034-6","article-title":"Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study","volume":"5","author":"Singla","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/jdv.19328","article-title":"Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - a population-based study","volume":"37","author":"Kridin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.12.025_bib20","doi-asserted-by":"crossref","first-page":"B106","DOI":"10.1016\/j.jaad.2022.06.456","article-title":"35304 safety and efficacy of COVID-19 vaccination in psoriasis patients","volume":"87","author":"Baker","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5114\/ada.2020.102089","article-title":"The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines","volume":"37","author":"Owczarek","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaad.2024.12.025_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/1756-185X.14750","article-title":"Absence of an association between gastrointestinal tract surgery and newly diagnosed psoriasis: a nationwide, population-based, nested, case-control study","volume":"26","author":"Liu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2024.12.025_bib25","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/1756-185X.14833","article-title":"Prevalence and risk factors associated with psoriatic arthritis among patients with psoriasis","volume":"26","author":"Loo","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2024.12.025_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jaad.2024.12.025_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S335517","article-title":"Positive predictive value of ICD-10 codes for cerebral venous sinus thrombosis in Taiwan\u2019s National Health Insurance Claims Database","volume":"14","author":"Liao","year":"2022","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jaad.2024.12.025_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106606","article-title":"Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: a multicenter retrospective research network study","volume":"188","author":"Hadi","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.jaad.2024.12.025_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ds.DS-D-23-00247","article-title":"Effectiveness of biologic treatment for psoriasis in Malaysia: real-world evidence and review of current evidence from Southeast Asia","volume":"42","author":"Kwan","year":"2024","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaad.2024.12.025_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijcard.2011.06.112","article-title":"Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis","volume":"151","author":"Avgerinou","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaad.2024.12.025_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaad.2024.12.025_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-016-8560-9","article-title":"The effect of tnf inhibitors on cardiovascular events in psoriasis and psoriatic arthritis: an updated meta-analysis","volume":"51","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2024.12.025_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaad.2016.07.042","article-title":"Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-alpha inhibitors versus methotrexate","volume":"76","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.12.025_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/1756-185X.14603","article-title":"Impact of targeted therapies on the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: a systematic review and aggregate data meta-analysis of randomized controlled trials","volume":"26","author":"Cai","year":"2023","journal-title":"Int J Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224034066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224034066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:54:49Z","timestamp":1744862089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224034066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0190962224034066"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12\/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}